- Search results for 2367001-70-3
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "2367001-70-3"!
Close filters
Filter by:
No results were found for the filter!
NEW
Item number: BPS-84232-1
Grisnilimab, also known as WT1, is a IgG2a monoclonal antibody targeting CD7 (cluster of differentiation 7). Grisnilimab has been conjugated to aglycosylated ricin toxin A (RTA) to generate grisnilimab setaritox, also named as WT-1-RTA, and tested for the treatment of graft-versus-host-disease (GvHD). The CD7...
| Keywords: | CD7, T-cell antigen CD7, GP40, T-cell leukemia antigen, T-cell surface antigen Leu-9, TP41 |
| Application: | ELISA, FC, FA |
| Host: | Mouse |
| CAS | 2367001-70-3 |
From 1,060.00€
*
Item number: TGM-T82260-1mg
Description: Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer). Target: Immunology/Inflammation...
| Keywords: | WT 1 , WT1 |
| CAS | 2367001-70-3 |
From 313.00€
*
